BeOne Medicines
ONC
#652
Rank
C$49.39 B
Marketcap
C$446.38
Share price
-2.56%
Change (1 day)
51.97%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total debt

Total debt on the balance sheet as of September 2025 : C$1.41 Billion

According to BeOne Medicines's latest financial reports the company's total debt is C$1.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BeOne Medicines - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$1.54 B25.6%
2023-12-31C$1.23 B52.38%
2022-12-31C$0.80 B-8.54%
2021-12-31C$0.88 B23.55%
2020-12-31C$0.71 B97.82%
2019-12-31C$0.36 B34.03%
2018-12-31C$0.27 B30.51%
2017-12-31C$0.20 B791.58%
2016-12-31C$23.22 M-19.45%
2015-12-31C$28.83 M79.56%
2014-12-31C$16.05 M-44.87%
2013-12-31C$29.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C$0.54 B-61.23%๐Ÿ‡บ๐Ÿ‡ธ USA